Chief Regulatory Officer, Biosciences Corporation
Dr. Chance has extensive regulatory strategy/ regulatory affairs experience working for a Clinical Research Organization and pharmaceutical and biopharmaceutical companies. She advises pharmaceutical and biotechnology companies in the development of region specific and/or global regulatory...
Read More →
Associate Director for Therapeutic Biologics, TBBT, OND, CDER, FDA
Dr. Christl is the Director of the Therapeutic Biologics and Biosimilars Staff (TBBS) in the Office of New Drugs in the FDA's CDER. TBBS is responsible for ensuring consistency in the scientific and regulatory approach and advice to sponsors regarding development programs for biosimilar...
Read More →
Executive Director, Scientific Affairs, Sandoz Inc., United States
Dr. Hillel P. Cohen PhD is Executive Director of Scientific Affairs at Sandoz, helping explain the principles of biosimilars and biosimilar policies to the healthcare community, patient advocacy groups, and health authorities. He has published and given presentations in the areas...
Read More →